The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
Appropriate candidates for the stack include post-surgical patients, those with severe or multiple injuries, athletes needing rapid return to competition, and individuals who tried BPC-157 alone with partial response
A: Generally, yes
Commonly investigated in dermatology and biomaterials research, AHK-Cu is used in models focused on collagen/elastin dynamics, inflammatory signaling balance, and oxidative-stress response.
The metabolism and elimination of NAD+ (and its by-products) could be altered in advanced hepatic or renal dysfunction, and high-dose NAD+ might theoretically affect cardiovascular dynamics, so practitioners generally avoid or closely supervise NAD+ use in such settings